Zhipeng Han

225 Changhai Road
Shanghai, 200438, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Glycochenodeoxycholic acid promotes hepatocarcinogenesis by inducing hepatic progenitor cell differentiation into cancer-associated fibroblasts via sphingosine-1-phosphate receptor 2 signalling.

Glycochenodeoxycholic acid promotes hepatocarcinogenesis by inducing hepatic progenitor cell differentiation into cancer-associated fibroblasts via sphingosine-1-phosphate receptor 2 signalling.

Journal: Biomarker research
Published: June 08, 2025

Farnesoid X receptor: a potential key target for maintaining liver organoid growth.

Farnesoid X receptor: a potential key target for maintaining liver organoid growth.

Journal: Biomaterials translational
Published: October 22, 2024

TWEAK Signaling-Induced ID1 Expression Drives Malignant Transformation of Hepatic Progenitor Cells During Hepatocarcinogenesis.

TWEAK Signaling-Induced ID1 Expression Drives Malignant Transformation of Hepatic Progenitor Cells During Hepatocarcinogenesis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 16, 2023

AIF1 + CSF1R + MSCs, induced by TNF-α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis.

AIF1 + CSF1R + MSCs, induced by TNF-α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis.

Journal: Hepatology (Baltimore, Md.)
Published: April 28, 2022

Doxorubicin-liposome combined with clodronate-liposome inhibits hepatocellular carcinoma through the depletion of macrophages and tumor cells.

Doxorubicin-liposome combined with clodronate-liposome inhibits hepatocellular carcinoma through the depletion of macrophages and tumor cells.

Journal: International journal of pharmaceutics
Published: April 28, 2022

An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity.

An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity.

Journal: Signal transduction and targeted therapy
Published: May 30, 2021

Correction: Kupffer cells-dependent inflammation in the injured liver increases recruitment of mesenchymal stem cells in aging mice.

Correction: Kupffer cells-dependent inflammation in the injured liver increases recruitment of mesenchymal stem cells in aging mice.

Journal: Oncotarget
Published: November 04, 2020

Autophagy and Tumour Metastasis.

Autophagy and Tumour Metastasis.

Journal: Advances in experimental medicine and biology
Published: July 17, 2020

Mesenchymal stem cell therapy for liver disease: full of chances and challenges.

Mesenchymal stem cell therapy for liver disease: full of chances and challenges.

Journal: Cell & bioscience
Published: April 30, 2020

Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma.

Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma.

Journal: Oncology reports
Published: February 17, 2020

Macrophages and hepatocellular carcinoma.

Macrophages and hepatocellular carcinoma.

Journal: Cell & bioscience
Published: June 25, 2019

BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling.

BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling.

Journal: Cell & bioscience
Published: February 02, 2019
Showing 1-12 of 30

Last Updated: 09/26/2026